(New York, NY) Mesoblast Ltd announced positive results for their year-long phase 2 clinical trial of mesenchymal precursor cells for the treatment of patients with chronic lower back pain.
Mesoblast Announces Phase 2 Clinical Results For Lower Back Pain (Mesoblast)
